Junji Wada

1.2k total citations
18 papers, 975 citations indexed

About

Junji Wada is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Junji Wada has authored 18 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Immunology and 6 papers in Oncology. Recurrent topics in Junji Wada's work include Immunotherapy and Immune Responses (6 papers), Immune Cell Function and Interaction (5 papers) and Hedgehog Signaling Pathway Studies (4 papers). Junji Wada is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Immune Cell Function and Interaction (5 papers) and Hedgehog Signaling Pathway Studies (4 papers). Junji Wada collaborates with scholars based in Japan and United States. Junji Wada's co-authors include Mitsuo Katano, Masao Tanaka, Shuntaro Nagai, Akio Yamasaki, Takashi Morisaki, Hideya Onishi, Kosuke Yanai, Hiroyuki Suzuki, Kenichiro Koga and Masafumi Nakamura and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and European Journal of Immunology.

In The Last Decade

Junji Wada

17 papers receiving 962 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junji Wada Japan 13 484 479 378 161 83 18 975
Akio Yamasaki Japan 15 477 1.0× 523 1.1× 391 1.0× 220 1.4× 86 1.0× 37 1.1k
Hong Nie China 11 338 0.7× 339 0.7× 245 0.6× 111 0.7× 47 0.6× 15 776
Mathieu Derouet Canada 15 609 1.3× 303 0.6× 451 1.2× 204 1.3× 39 0.5× 24 1.1k
Yulan Qing United States 11 289 0.6× 276 0.6× 311 0.8× 83 0.5× 47 0.6× 17 698
Yael Raz Israel 12 614 1.3× 682 1.4× 451 1.2× 263 1.6× 34 0.4× 17 1.2k
Tomasz Herjan United States 13 354 0.7× 251 0.5× 674 1.8× 169 1.0× 76 0.9× 17 1.0k
Jun Ye China 12 378 0.8× 335 0.7× 232 0.6× 243 1.5× 50 0.6× 18 850
H. Mytrang United States 10 378 0.8× 353 0.7× 454 1.2× 190 1.2× 35 0.4× 14 963
Nicolò Rigamonti Switzerland 6 375 0.8× 404 0.8× 344 0.9× 188 1.2× 45 0.5× 11 780

Countries citing papers authored by Junji Wada

Since Specialization
Citations

This map shows the geographic impact of Junji Wada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junji Wada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junji Wada more than expected).

Fields of papers citing papers by Junji Wada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junji Wada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junji Wada. The network helps show where Junji Wada may publish in the future.

Co-authorship network of co-authors of Junji Wada

This figure shows the co-authorship network connecting the top 25 collaborators of Junji Wada. A scholar is included among the top collaborators of Junji Wada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junji Wada. Junji Wada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wada, Junji, Hideya Onishi, Hiroyuki Suzuki, et al.. (2010). Surface-bound TGF-beta1 on effusion-derived exosomes participates in maintenance of number and suppressive function of regulatory T-cells in malignant effusions.. PubMed. 30(9). 3747–57. 68 indexed citations
2.
Onishi, Hideya, Junji Wada, Hideyuki Suzuki, et al.. (2010). Effect of TGF-β1 expressed on tumor-derived exosomes on survival and function of regulatory T cells.. Journal of Clinical Oncology. 28(15_suppl). 2567–2567. 2 indexed citations
3.
Nakamura, Masafumi, Junji Wada, Hiroyuki Suzuki, et al.. (2009). Long-term outcome of immunotherapy for patients with refractory pancreatic cancer.. PubMed. 29(3). 831–6. 24 indexed citations
4.
Nakamura, Masafumi, Haruo Tanaka, Akio Yamasaki, et al.. (2009). Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/MyD88 signaling pathway. Journal of Surgical Oncology. 100(8). 725–731. 146 indexed citations
5.
Xu, Rui, Norihiro Sato, Kosuke Yanai, et al.. (2009). Enhancement of paclitaxel-induced apoptosis by inhibition of mitogen-activated protein kinase pathway in colon cancer cells.. PubMed. 29(1). 261–70. 53 indexed citations
6.
Suzuki, Hiroyuki, Hideya Onishi, Junji Wada, et al.. (2009). VEGFR2 is selectively expressed by FOXP3high CD4+ Treg. European Journal of Immunology. 40(1). 197–203. 104 indexed citations
7.
Yamasaki, Akio, Hiroko Iijima, Shuntaro Nagai, et al.. (2009). A protein-bound polysaccharide, PSK, enhances tumor suppression induced by docetaxel in a gastric cancer xenograft model.. PubMed. 29(3). 843–50. 16 indexed citations
8.
Wada, Junji, Hiroyuki Suzuki, Akio Yamasaki, et al.. (2009). The contribution of vascular endothelial growth factor to the induction of regulatory T-cells in malignant effusions.. PubMed. 29(3). 881–8. 138 indexed citations
9.
Suzuki, Hiroyuki, Takehiko Tasaka, Junji Wada, et al.. (2009). Intratumoral CD8+ T/FOXP3+ cell ratio is a predictive marker for survival in patients with colorectal cancer. Cancer Immunology Immunotherapy. 59(5). 653–661. 148 indexed citations
10.
Nagai, Shuntaro, Masafumi Nakamura, Kosuke Yanai, et al.. (2008). Gli1contributes to the invasiveness of pancreatic cancer through matrix metalloproteinase‐9 activation. Cancer Science. 99(7). 1377–1384. 60 indexed citations
11.
Yanai, Kosuke, Masafumi Nakamura, Takashi Akiyoshi, et al.. (2008). Crosstalk of hedgehog and Wnt pathways in gastric cancer. Cancer Letters. 263(1). 145–156. 55 indexed citations
12.
Wada, Junji, Akio Yamasaki, Shuntaro Nagai, et al.. (2008). Regulatory T-cells are possible effect prediction markers of immunotherapy for cancer patients.. PubMed. 28(4C). 2401–8. 20 indexed citations
13.
Akiyoshi, Takashi, Masafumi Nakamura, Kosuke Yanai, et al.. (2007). γ-Secretase Inhibitors Enhance Taxane-Induced Mitotic Arrest and Apoptosis in Colon Cancer Cells. Gastroenterology. 134(1). 131–144. 77 indexed citations
14.
Yanai, Kosuke, Shuntaro Nagai, Junji Wada, et al.. (2006). Hedgehog signaling pathway is a possible therapeutic target for gastric cancer. Journal of Surgical Oncology. 95(1). 55–62. 55 indexed citations
15.
Wada, Yoshito, et al.. (2004). A SURGICAL CASE OF DUBIN-JOHNSON SYNDROME ASSOCIATED WITH COLON CANCER. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 65(7). 1904–1908.
16.
Onishi, Hideya, Takashi Morisaki, Mitsuo Katano, et al.. (2002). A LARGE QUANTITY OF CD3/CD19/CD16LYMPHOCYTES IN MALIGNANT PLEURAL EFFUSION FROM A PATIENT WITH RECURRENT CHOLANGIO CELL CARCINOMA. Immunological Investigations. 31(2). 121–135. 4 indexed citations
17.
Togashi, Kenji, et al.. (1984). Effects of Breed, Finish Period and Feeding Rate of Concentrates on Finish of Steers Raised on Range or Pasture. Nihon Chikusan Gakkaiho. 55(12). 947–951. 2 indexed citations
18.
Hakozaki, Hando, et al.. (1979). SYNDROME OF THE SEA‐BLUE HISTIOCYTE —The First Case Report in Japan and Review of the Literature—. Acta Pathologica Japonica. 29(1). 73–97. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026